NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »           NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »          NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »

The Latest Research From Our Experts

Ensuring that the right patients are enrolled in a clinical trial is critical for both patient safety and the integrity of study outcomes. Download this case study today to see how InformedDNA’s adjudication support impacted a recent clinical trial.

Genetic counseling plays a critical role in accurately interpreting genetic test results, guiding decision-making for both patients and providers. Unfortunately, there are a limited number of genetic counselors. The answer lies in outsourcing genetic services as a way of tapping into external expertise and enhancing operational efficiency. This approach not only alleviates the burden on […]

Patient diversity and inclusion are essential to rare disease research progress. Why? Because people with the same disease may experience it differently. With a US population comprised of 40% racial and ethnic minorities[1],it’s essential that clinical trials reflect a variety of lived experiences, as well as characteristics like ethnicity, age, and gender, so that all […]

To date, 760 orphan drugs have been approved by US and European agencies to treat nearly 7,000 identified rare diseases. With 80% having a genetic component, genetic testing and the use of its data have become essential ingredients to the successful diagnosis and treatment of rare diseases. Yet incorporating that genetic data into the clinical […]

How can we help?

Reach out today to discover how our dynamic solutions can help your organization make informed decisions, manage utilization of genetic tests, and control costs for cost-effective enhanced patient care and better outcomes for all.

×